Impax Asset Management Group PLC Ligand Pharmaceuticals Inc Transaction History

Impax Asset Management Group PLC

$22.9 Billion
Q2 2024

A detailed history of Impax Asset Management Group PLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Impax Asset Management Group PLC holds 280,208 shares of LGND stock, worth $28.1 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

280,208

Previous 255,208 9.8%

Holding current value

$28.1 Million

Previous $18.7 Million 26.56%

% of portfolio

0.1%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$68.53 - $87.91 $1.71 Million - $2.2 Million	25,000 Added 9.8%	280,208 $23.6 Million
Q1 2024 Apr 30, 2024	BUY	$68.64 - $89.2 $3.43 Million - $4.46 Million	50,000 Added 24.37%	255,208 $18.7 Million
Q4 2023 Jan 26, 2024	BUY	$49.57 - $72.63 $1.04 Million - $1.52 Million	20,888 Added 11.33%	205,208 $14.7 Million
Q3 2023 Nov 07, 2023	BUY	$58.86 - $72.67 $1.47 Million - $1.82 Million	25,000 Added 15.69%	184,320 $11 Million
Q2 2023 Aug 07, 2023	SELL	$69.53 - $79.33 $2.43 Million - $2.78 Million	-35,000 Reduced 18.01%	159,320 $11.5 Million
Q1 2023 May 10, 2023	SELL	$65.67 - $77.08 $2.63 Million - $3.08 Million	-40,000 Reduced 17.07%	194,320 $14.3 Million
Q3 2022 Nov 08, 2022	BUY	$0.01 - $107.56 $500 - $5.38 Million	50,000 Added 27.13%	234,320 $20.2 Million
Q2 2022 Aug 11, 2022	BUY	$74.52 - $117.06 $1.49 Million - $2.34 Million	20,000 Added 12.17%	184,320 $16.4 Million
Q1 2022 May 16, 2022	BUY	$94.99 - $151.56 $2.8 Million - $4.47 Million	29,500 Added 21.88%	164,320 $18.5 Million
Q4 2021 Feb 14, 2022	BUY	$127.69 - $165.85 $4.53 Million - $5.89 Million	35,500 Added 35.74%	134,820 $20.8 Million
Q3 2021 Nov 12, 2021	BUY	$102.33 - $144.73 $2.05 Million - $2.89 Million	20,000 Added 25.21%	99,320 $13.8 Million
Q2 2021 Aug 05, 2021	SELL	$113.03 - $155.64 $575,435 - $792,363	-5,091 Reduced 6.03%	79,320 $10.4 Million
Q1 2021 May 14, 2021	SELL	$99.52 - $215.83 $4.1 Million - $8.88 Million	-41,156 Reduced 32.78%	84,411 $12.9 Million
Q3 2020 Nov 12, 2020	BUY	$89.56 - $126.72 $782,575 - $1.11 Million	8,738 Added 7.48%	125,567 $12 Million
Q1 2020 May 15, 2020	BUY	$63.37 - $107.88 $2.53 Million - $4.32 Million	40,000 Added 52.06%	116,829 $8.5 Million
Q4 2019 Feb 13, 2020	BUY	$96.94 - $113.59 $438,750 - $514,108	4,526 Added 6.26%	76,829 $8.01 Million
Q2 2019 Aug 13, 2019	SELL	$107.38 - $129.34 $929,481 - $1.12 Million	-8,656 Reduced 10.69%	72,303 $8.25 Million
Q4 2018 Feb 14, 2019	BUY	$128.36 - $272.13 $6.42 Million - $13.6 Million	50,000 Added 161.5%	80,959 $11 Million
Q3 2018 Nov 14, 2018	BUY	$211.18 - $274.49 $6.54 Million - $8.5 Million	30,959 New	30,959 $8.5 Million

Others Institutions Holding LGND

# of Institutions

247

Shares Held

17.5M

Call Options Held

61K

Put Options Held

7.8K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.69B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Impax Asset Management Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Impax Asset Management Group PLC with notifications on news.

Account

Impax Asset Management Group PLC Ligand Pharmaceuticals Inc Transaction History